{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:20:17Z","timestamp":1794932417270,"version":"4.9.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129084","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:12:49Z","timestamp":1787836369000},"page":"129084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Central nervous system safety risks and evaluation strategies for mucosal vaccines: A review"],"prefix":"10.1016","volume":"91","author":[{"given":"Qianying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129084_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal Immunity and Vaccination Strategies: Current Insights and Future Perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.vaccine.2026.129084_bb0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-Resident Memory T Cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.129084_bb0015","article-title":"Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection","volume":"9","author":"Vaca","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2026.129084_bb0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal Vaccines \u2014 Fortifying the Frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0025","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, Tolerability, and Immunogenicity of an Aerosolised Adenovirus Type-5 Vector-Based COVID-19 Vaccine (Ad5-nCoV) in Adults: Preliminary Report of an Open-Label and Randomised Phase 1 Clinical Trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129084_bb0030","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.vaccine.2017.09.034","article-title":"Cholera Vaccine: WHO Position Paper, August 2017 \u2013 Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129084_bb0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell\u2019s Palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.129084_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","article-title":"Mucosal Immune Response in Biology, Disease Prevention and Treatment","volume":"10","author":"Zhou","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.129084_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14760584.2023.2268724","article-title":"Mucosal Vaccination: Onward and Upward","volume":"22","author":"Tsai","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17425247.2020.1731468","article-title":"Non-Invasive Mucosal Vaccine Delivery: Advantages, Challenges and the Future","volume":"17","author":"Skwarczynski","year":"2020","journal-title":"EXPERT OPIN DRUG DEL"},{"key":"10.1016\/j.vaccine.2026.129084_bb0055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117083119","article-title":"Passage of exogeneous fine particles from the lung into the brain in humans and animals","volume":"119","author":"Qi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.129084_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070929","article-title":"Nasal drug delivery and nose-to-brain delivery technology development status and trend analysis: based on questionnaire survey and patent analysis","volume":"16","author":"Ge","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.129084_bb0065","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier","volume":"13","author":"Lee","year":"2021","journal-title":"PHARMACEUTICS"},{"key":"10.1016\/j.vaccine.2026.129084_bb0070","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41467-018-04569-y","article-title":"TLR9 Activation via Microglial Glucocorticoid Receptors Contributes to Degeneration of Midbrain Dopamine Neurons","volume":"9","author":"Maatouk","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129084_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The Blood-Brain Barrier in Systemic Inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.vaccine.2026.129084_bb0080","series-title":"Principles of Mucosal Immunology","year":"2020"},{"key":"10.1016\/j.vaccine.2026.129084_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127356","article-title":"A Review of Currently Licensed Mucosal COVID-19 Vaccines","volume":"61","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129084_bb0090","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/vaccines11101585","article-title":"Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens","volume":"11","author":"Dotiwala","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent Progress in Mucosal Vaccine Development: Potential and Limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0100","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.apsb.2022.07.002","article-title":"Mucosal Vaccine Delivery: A Focus on the Breakthrough of Specific Barriers","volume":"12","author":"Huang","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.vaccine.2026.129084_bb0105","article-title":"Targeting respiratory viruses: the efficacy of intranasal mRNA vaccination in generating protective mucosal and systemic immunity against influenza A (H1N1)","volume":"19","author":"Yahyaei","year":"2025","journal-title":"Influenza Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.129084_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molmed.2022.10.009","article-title":"Nasal Vaccines: Solutions for Respiratory Infectious Diseases","volume":"29","author":"Nakahashi-Ouchida","year":"2023","journal-title":"TRENDS MOL MED"},{"key":"10.1016\/j.vaccine.2026.129084_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","article-title":"Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities\u2014Workshop Report","volume":"8","author":"Knisely","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9010001","article-title":"Advances in Oral Subunit Vaccine Design","volume":"9","author":"Van Der Weken","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.129084_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.129084_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.129084_bb0140","series-title":"Mucosal Vaccines","first-page":"649","article-title":"Mucosal Vaccines for Oral Disease","author":"Kurita-Ochiai","year":"2020"},{"key":"10.1016\/j.vaccine.2026.129084_bb0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.129084_bb0150","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-024-01743-y","article-title":"Characteristics of Blood-Brain Barrier Heterogeneity between Brain Regions Revealed by Profiling Vascular and Perivascular Cells","volume":"27","author":"Pfau","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.vaccine.2026.129084_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.vaccine.2026.129084_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-025-00481-w","article-title":"Nose-to-Brain Drug Delivery: From Bench to Bedside","volume":"14","author":"Drath","year":"2025","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.vaccine.2026.129084_bb0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2026.129084_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109651","article-title":"IL-1\u03b2 Disrupts the Initiation of Blood-Brain Barrier Development by Inhibiting Endothelial Wnt\/\u03b2-Catenin Signaling","volume":"27","author":"Fetsko","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2026.129084_bb0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/pharmaceutics16040481","article-title":"Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport","volume":"16","author":"Gandhi","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.129084_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-Brain Barrier Dysfunction and Alzheimer\u2019s Disease: Associations, Pathogenic Mechanisms, and Therapeutic Potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.vaccine.2026.129084_bb0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.vaccine.2026.129084_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of Neuroinflammation in Neurodegeneration Development","volume":"8","author":"Zhang","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.129084_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 Vaccines: From Bench to Bed","volume":"76","author":"Alu","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.vaccine.2026.129084_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/vaccines13030261","article-title":"Safety Assessment of a Sublingual Vaccine Formulated with Poly(I:C) Adjuvant and Influenza HA Antigen in Mice and Macaque Monkeys: Comparison with Intranasal Vaccine","volume":"13","author":"Yamamoto","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10030405","article-title":"Nasal nanovaccines for SARS-CoV-2 to address COVID-19","volume":"10","author":"Huang","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0215","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.vaccine.2023.05.011","article-title":"Advances in Intranasal Vaccine Delivery: A Promising Non-Invasive Route of Immunization","volume":"41","author":"Kehagia","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129084_bb0235","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acschemneuro.0c00172","article-title":"SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection","volume":"11","author":"Butowt","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.vaccine.2026.129084_bb0240","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41541-025-01240-8","article-title":"Modulation of Oral Vaccine Efficacy by the Gut Microbiota","volume":"10","author":"Hou","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129084_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.129084_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03481-0","article-title":"Gastrointestinal exposure to silica nanoparticles induced Alzheimer\u2019s disease-like neurotoxicity in mice relying on gut microbiota and modulation through TLR4\/NF-\u03baB and HDAC","volume":"23","author":"Du","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0260","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","article-title":"Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence","volume":"27","author":"Yeh","year":"2020","journal-title":"Cell Host & Microbe"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.129084_bb0265","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden","volume":"210","author":"Platt","year":"2014","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2026.129084_bb0270","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1039\/D4LC00273C","article-title":"A gut\u2013brain axis on-a-chip platform for drug testing challenged with donepezil","volume":"25","author":"Fanizza","year":"2025","journal-title":"Lab Chip"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129084_bb0275","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/smim.1997.0086","article-title":"Challenges for Vaccination against Sexually-Transmitted Diseases: Induction and Long-Term Maintenance of Mucosal Immune Responses in the Female Genital Tract","volume":"9","author":"Rosenthal","year":"1997","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.vaccine.2026.129084_bb0280","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2026.129084_bb0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.6026\/97320630011047","article-title":"Evidence-based decision practice-based research network. Viral immune surveillance: toward a TH17\/TH9 gate to the Central Nervous System","volume":"11","author":"UCLA School of Dentistry Oral Biology& Medicine, Evidence-Based Decision Practice-Based Research Network","year":"2015","journal-title":"Bioinformation"},{"key":"10.1016\/j.vaccine.2026.129084_bb0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal Vaccines: The Promise and the Challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"34","key":"10.1016\/j.vaccine.2026.129084_bb0295","first-page":"477","article-title":"Cholera vaccines: WHO position paper\u2014August 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.129084_bb0300","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 Inflammasome Is Critical for Aluminium Hydroxide-Mediated IL-1beta Secretion but Dispensable for Adjuvant Activity","volume":"38","author":"Franchi","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tox.2016.11.018","article-title":"Non-Linear Dose-Response of Aluminium Hydroxide Adjuvant Particles: Selective Low Dose Neurotoxicity","volume":"375","author":"Cr\u00e9peaux","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.vaccine.2026.129084_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201813666160804121123","article-title":"Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine","volume":"14","author":"Li","year":"2017","journal-title":"CDD"},{"key":"10.1016\/j.vaccine.2026.129084_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/polym17111453","article-title":"Chitosan nanoparticle-based drug delivery systems: advances, challenges, and future perspectives","volume":"17","author":"Stefanache","year":"2025","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.vaccine.2026.129084_bb0320","series-title":"Chitosan-Based Nanoparticles for Biomedical Applications","first-page":"373","article-title":"Chapter 19 - Chitosan Based Nanocarriers for Delivery of Therapeutic Agents","author":"Ogundolie","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129084_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28041963","article-title":"Chitosan-based nanoparticles as effective drug delivery systems\u2014a review","volume":"28","author":"Jafernik","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2026.129084_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060746","article-title":"Chitosan nanoparticles for intranasal drug delivery","volume":"16","author":"Omidian","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.129084_bb0170","doi-asserted-by":"crossref","first-page":"12343","DOI":"10.2147\/IJN.S497480","article-title":"Nose to brain: exploring the progress of intranasal delivery of solid lipid nanoparticles and nanostructured lipid carriers","volume":"19","author":"Zheng","year":"2024","journal-title":"IJN"},{"key":"10.1016\/j.vaccine.2026.129084_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of Insulin-like Growth Factor-I to the Rat Brain and Spinal Cord along Olfactory and Trigeminal Pathways Following Intranasal Administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.vaccine.2026.129084_bb0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of Intranasal Drug Delivery Directly to the Brain","volume":"195","author":"Crowe","year":"2018","journal-title":"LIFE SCI"},{"key":"10.1016\/j.vaccine.2026.129084_bb0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug Delivery to the Brain via the Nasal Route of Administration: Exploration of Key Targets and Major Consideration Factors","volume":"53","author":"Jeong","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.vaccine.2026.129084_bb0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/etm.2024.12511","article-title":"Recent Development of Oral Vaccines (Review)","volume":"27","author":"Liu","year":"2024","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.vaccine.2026.129084_bb0345","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0350","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.4049\/jimmunol.1001789","article-title":"In Vivo Molecular Imaging Analysis of a Nasal Vaccine That Induces Protective Immunity against Botulism in Nonhuman Primates","volume":"185","author":"Yuki","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0355","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel Antigenic Protein-Delivery System for Adjuvant-Free Intranasal Vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat Mater"},{"key":"10.1016\/j.vaccine.2026.129084_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139368","article-title":"Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice","volume":"10","author":"Fukuyama","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2026.129084_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70079","article-title":"Endothelial dysfunctions in Blood\u2013Brain Barrier breakdown in Alzheimer\u2019s Disease: from mechanisms to potential therapies","volume":"30","author":"Yue","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.vaccine.2026.129084_bb0370","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2026.129084_bb0375","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2026.129084_bb0380","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0273-2300(03)00089-8","article-title":"Local Tolerance Testing of Parenteral Drugs: How to Put into Practice","volume":"38","author":"Jochims","year":"2003","journal-title":"Regul Toxicol Pharm"},{"key":"10.1016\/j.vaccine.2026.129084_bb0385","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal Drug Delivery\u2014Possibilities, Problems and Solutions","volume":"87","author":"Illum","year":"2003","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.vaccine.2026.129084_bb0390","series-title":"WHO Technical Report Series, No. 1004","article-title":"Annex 9: Guidelines on clinical evaluation of vaccines: regulatory expectations (Replacement of Annex 1 of WHO Technical Report Series, No. 924)","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.vaccine.2026.129084_bb0395","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"389","author":"Zhu","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2026.129084_bb0400","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral Vectored Vaccines: Design, Development, Preventive and Therapeutic Applications in Human Diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.129084_bb0405","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1474-4422(17)30123-0","article-title":"Olfactory Dysfunction in Neurodegenerative Diseases: Is There a Common Pathological Substrate?","volume":"16","author":"Doty","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2026.129084_bb0410","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","article-title":"Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline","volume":"76","author":"Taipa","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.vaccine.2026.129084_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12040430","article-title":"Magnetic resonance imaging confirmed olfactory bulb reduction in long COVID-19: literature review and case series","volume":"12","author":"Frosolini","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.vaccine.2026.129084_bb0420","author":"ICH"},{"key":"10.1016\/j.vaccine.2026.129084_bb0425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pds.5548","article-title":"Methods for Drug Safety Signal Detection Using Routinely Collected Observational Electronic Health Care Data: A Systematic Review","volume":"32","author":"Coste","year":"2023","journal-title":"PHARMACOEPIDEM DR S"},{"key":"10.1016\/j.vaccine.2026.129084_bb0430","article-title":"Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines","volume":"14","author":"Dutta","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.vaccine.2026.129084_bb0435","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s12325-018-0747-4","article-title":"Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis","volume":"35","author":"De Lusignan","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2026.129084_bb0440","article-title":"Machine Learning Approach for Active Vaccine Safety Monitoring","volume":"36","author":"Kim","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2026.129084_bb0445","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0264-410X(00)00412-6","article-title":"Effects of Intranasal Administration of Cholera Toxin (or Escherichia Coli Heat-Labile Enterotoxin) B Subunits Supplemented with a Trace Amount of the Holotoxin on the Brain","volume":"19","author":"Hagiwara","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129084_bb0450","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/491739","article-title":"Proinflammatory Responses in the Murine Brain after Intranasal Delivery of Cholera Toxin: Implications for the Use of AB Toxins as Adjuvants in Intranasal Vaccines","volume":"192","author":"Armstrong","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:51:16Z","timestamp":1794930676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":89,"alternative-id":["S0264410X26008935"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central nervous system safety risks and evaluation strategies for mucosal vaccines: A review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129084"}}